Zepp Health Corporation
NYSE:ZEPPConsumer Electronics
-$0.03 today
- Market cap
- $50.84M
- Beta
- 1.78
- P/E (TTM)
- -0.1
- EPS (TTM)
- -$282.07
Volume 0.04M
Average 0.13M
ZEPP Retained Earnings
Cumulative profits kept in the business rather than paid out as dividends.
Zepp Health CorporationNYSE: ZEPP
Retained Earnings · Q1 FY2026 · quarter ended Mar 2026
Retained earnings turns negative
Q1 FY2026 retained earnings was -CN¥214M, compared with CN¥64.47M a year earlier.
Context
- Retained earnings amounted to 5.8% of total assets at the end of Q1 FY2026, up 4.1 pp from a year earlier.
- Retained earnings increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether retained earnings keeps falling in the next quarterly balance sheet after a -431.9% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Retained Earnings history
CNY · from the balance sheet
- Latest · FY2025
- (80.07M) CNY
- Year-over-year change
- -138.3%
| Period | Period end | Retained Earnings | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (80.07M) | -138.3% |
| FY2024 | 2024-12-31 | 208.88M | -71.7% |
| FY2023 | 2023-12-31 | 739.23M | -20.5% |
| FY2022 | 2022-12-31 | 929.32M | -26.8% |
| FY2021 | 2021-12-31 | 1.27B | — |
Retained Earnings vs competitors
How ZEPP compares with its peers on the latest reported figures
- Peers report in different currencies, so retained earnings is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of -431.9% is the lowest of 8, against a peer median of -31.4%.
- Retained earnings amounts to 5.8% of total assets for ZEPP, versus a peer median of 164.8%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $346.54M USD | -36.8% | -27.0% | 24.5% | |
SVCOSilvaco Group, Inc. Common Stock | Mar 2026 | -$75.08M USD | -58.8% | — | 67.4% |
| Dec 2025 | -$116.92M USD | -31.4% | — | 169.3% | |
| Mar 2026 | -$173.83M USD | -69.4% | — | 164.8% | |
| Mar 2026 | -$174.55M USD | -13.3% | — | 91.6% | |
| Mar 2026 | -CN¥214M CNY | -431.9% | — | 5.8% | |
| Mar 2026 | -$1.51B USD | +8.7% | — | 534.9% | |
| Mar 2026 | -$1.78B USD | -6.3% | — | 234.5% | |
| Peer median (excluding ZEPP) | — | -31.4% | -27.0% | 164.8% | |
Competitors are the stored peer set for ZEPP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 1.51B | 959.38M | 995.09M | 808.23M | 789.7M |
| Short-term Investments | 24.32M | 33.82M | 36.5M | 7.28M | 0 |
| Net Receivables | 1.09B | 857.83M | 580.63M | 577.66M | 514.47M |
| Inventory | 1.26B | 1.01B | 601.38M | 414.51M | 508.76M |
| Other Current Assets | 815.05K | 3.17M | 1.63M | 1.7M | 239.59M |
| Total Current Assets | 3.93B | 2.92B | 2.24B | 1.84B | 2.05B |
| Property, Plant & Equipment (Net) | 242.02M | 163.79M | 111.56M | 75.59M | 53.28M |
| Goodwill | 60.98M | 65.13M | 67.87M | 69.93M | 67M |
| Intangible Assets | 135.42M | 121.53M | 69.91M | 51.76M | 95.18M |
| Long-term Investments | 1.55B | 1.67B | 1.71B | 1.66B | 1.55B |
| Tax Assets | 143.25M | 207.17M | 229.53M | 127.47M | 110.08M |
| Other Non-current Assets | 19.57M | 49.67M | 68.7M | 33.63M | 26M |
| Total Non-current Assets | 2.15B | 2.28B | 2.26B | 2.02B | 1.9B |
| Total Assets | 6.08B | 5.19B | 4.5B | 3.86B | 3.95B |
| Account Payables | 1.32B | 450.04M | 264.14M | 372.8M | 564.78M |
| Short-term Debt | 550.43M | 996.26M | 513.98M | 765.56M | 1.17B |
| Tax Payables | 2.6M | 2.72M | 3.64M | 4.16M | 0 |
| Deferred Revenue | 92.1M | 62.39M | 55.51M | 37.54M | 531.44K |
| Other Current Liabilities | 146.82M | 107.87M | 244.39M | 232.37M | 266.99M |
| Total Current Liabilities | 2.15B | 1.64B | 1.1B | 1.43B | 2.01B |
| Long-term Debt | 726M | 674.4M | 850.23M | 549.17M | 415.89M |
| Deferred Tax Liabilities | 26.88M | 35.04M | 29.53M | 22.75M | 18.69M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 174.85M | 160.27M | 1.91M | 970.73K | 1.46M |
| Total Non-current Liabilities | 998.75M | 900.94M | 904.32M | 587.54M | 443.75M |
| Total Liabilities | 3.15B | 2.55B | 2B | 2.01B | 2.45B |
| Common Stock | 158.81K | 159.67K | 184.19K | 189.76K | 181.81K |
| Retained Earnings | 1.27B | 929.32M | 739.23M | 208.88M | (80.07M) |
| Accumulated OCI | 29.24M | 104.28M | (99.23M) | (293.25M) | (278.87M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | (14) |
| Minority Interest | 13.08M | 12.22M | 13.25M | 8.31M | 0 |
| Total Equity | 2.93B | 2.65B | 2.5B | 1.84B | 1.5B |
| Total Debt | 1.35B | 1.7B | 1.39B | 1.33B | 1.59B |
| Net Debt | (160.3M) | 742.51M | 391.76M | 521.15M | 804.83M |
Zepp Health Corporation
NYSE:ZEPP
Intrinsic Alpha fair value
Locked
Current Price
$3.55
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.